Peter Fong - Sep 24, 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ John Militello, as attorney-in-fact for Peter Fong
Stock symbol
RCKT
Transactions as of
Sep 24, 2025
Transactions value $
$0
Form type
4
Date filed
10/3/2025, 08:33 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fong Peter Director C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ John Militello, as attorney-in-fact for Peter Fong 2025-10-03 0002062181

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Award $0 +23.3K $0.00 23.3K Sep 24, 2025 Direct F1
transaction RCKT Common Stock Award $0 +30K +128.57% $0.00 53.3K Sep 24, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on September 24, 2026.
F2 Represents RSUs that will vest in equal monthly installments over a three-year period following September 23, 2025.